Related Experiment Video
Updated: Mar 16, 2026
05:17
Intravenous Injections in Neonatal Mice
Published on: November 11, 2014
62.0K
Why do parents decline newborn intramuscular vitamin K prophylaxis?
Hayleigh Miller1, Nicola Kerruish2, Roland S Broadbent3
1Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
Journal of Medical Ethics
|August 10, 2016
Summary
Parents decline vitamin K shots for newborns due to beliefs, child welfare concerns, and external influences. This hesitancy mirrors broader concerns about medical interventions for children.
Area of Science:
- Pediatrics
- Public Health
- Qualitative Research
Background:
- Newborns are at risk for vitamin K deficiency bleeding (VKDB).
- Intramuscular (IM) vitamin K prophylaxis is a standard preventative measure.
- Parental decisions to opt out of IM vitamin K impact public health strategies.
Purpose of the Study:
- To investigate the reasons behind parents opting out of IM vitamin K prophylaxis for their newborns.
- To understand the influencing factors in parental decision-making regarding newborn vitamin K administration.
Main Methods:
- Qualitative study employing semistructured interviews with 15 families.
- Thematic analysis was used to identify key themes in parental decision-making.
- Study conducted in the Otago/Southland region of New Zealand.
Main Results:
- Parental decisions were influenced by beliefs and values (philosophy, spirituality).
- Concerns about child welfare, including pain and potential side effects, were significant.
- External factors such as family, friends, media, and healthcare professionals played a role.
- Many parents expressed broader hesitancy towards medical interventions.
Conclusions:
- Parental decisions to opt out of IM vitamin K are multifactorial.
- Findings highlight parallels with decisions regarding other childhood interventions.
- Understanding these factors is crucial for addressing vaccine hesitancy and improving informed consent processes for newborn care.
More Related Videos
10:15Intracerebroventricular Viral Injection of the Neonatal Mouse Brain for Persistent and Widespread Neuronal Transduction
Published on: September 15, 2014
64.1K
04:33Author Spotlight: Intrathecal Injection – An Efficient and Reliable Delivery Method to Test the Efficacy of Gene Editing in Neonatal Mouse Brains
Published on: March 8, 2024
6.2K
Related Concept Videos
01:29Drug Dosing: Infants and Children
687
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
687
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.7K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
01:29Venous Thrombosis III: Interprofessional Care
453
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
453
01:24Parenteral Anesthetics: Overview
870
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
870
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
354
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
354
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K